Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Helena Iznardo"'
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 385 (2023)
Abrocitinib is a JAK1 selective inhibitor recently approved for the treatment of moderate-to-severe atopic dermatitis in adults. It has demonstrated efficacy and safety in several clinical trials, both in children and adults, in monotherapy, and comp
Externí odkaz:
https://doaj.org/article/dd62a626ad9c4c11bba240962449cd4c
Autor:
Helena Iznardo, Lluís Puig
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Psoriasis and psoriatic arthritis are chronic immune-mediated disorders with involvement of interleukin (IL)-17 cytokines in their pathogenesis. IL-17A has been considered to be the most biologically active, but IL-17F is also over-expressed in skin
Externí odkaz:
https://doaj.org/article/aaf68bca968544e5b939d4f094b1228c
Autor:
Helena Iznardo, Luís Puig
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 9479 (2022)
The interleukin-1 (IL-1) family is involved in the correct functioning and regulation of the innate immune system, linking innate and adaptative immune responses. This complex family is composed by several cytokines, receptors, and co-receptors, all
Externí odkaz:
https://doaj.org/article/aca9741663f44ab5a345db22f5d59bcd
Autor:
Helena Iznardo, Lluís Puig
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 9, p 4344 (2021)
Unmet needs in the treatment of psoriasis call for novel therapeutic strategies. Pustular psoriasis and psoriatic arthritis often represent a therapeutic challenge. Focus on IL-36 cytokines offers an interesting approach, as the IL-36 axis has been a
Externí odkaz:
https://doaj.org/article/9e0ac3e9cbc34eb793074aa206a0d77e
Publikováno v:
Piel. 38:46-52
Autor:
Helena Iznardo, Cecilie Bredrup, Sara Bernal, Titas Gladkauskas, José‐Manuel Mascaró, Esther Roé, Eulalia Baselga
Publikováno v:
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Penttinen type of premature aging syndrome is an autosomal-dominant disorder that can be caused by the c.1994T>A pVal665Ala pathogenic variant in platelet-derived growth factor receptor-B (PDGFRB). Imatinib, a receptor tyrosine kinase (RTK) inhibitor
Autor:
Helena Iznardo, Lluís Puig
Publikováno v:
Current opinion in rheumatology. 34(4)
Psoriasis vulgaris is the commonest presentation of psoriatic disease, but morphologic variants such as pustular psoriasis (PP) and a closely related disease, pityriasis rubra pilaris (PRP), have been known for a long time, have been associated with
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology. 13:837-855
Lentigo maligna (LM) is a type of melanoma in situ that has distinctive characteristics regarding epidemiology, risk factors and clinical features. In addition, LM has a potential to progress to an invasive tumor with potentially aggressive behavior:
Publikováno v:
British Journal of Dermatology. 185:660-662
Publikováno v:
International journal of dermatologyReferences. 61(10)